ArticleCureus2025
Trends in the Incidence of Ramsay Hunt Syndrome and Zoster Sine Herpete Following the Introduction of Routine Varicella Vaccination in Hokkaido, Japan.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRoutine varicella vaccination was introduced in Japan in October 2014. A large-scale epidemiological study conducted in Miyazaki Prefecture subsequently reported a marked increase in the incidence of herpes zoster (HZ) among the child-rearing population aged 20-40 years following this introduction.
objectiveThis study aimed to investigate long-term trends in the incidence of HZ-related facial palsy, Ramsay Hunt syndrome (RHS) and zoster sine herpete (ZSH), among patients with acute peripheral facial palsy (APFP) aged 15 years or older, treated at a single institution in Hokkaido, Japan, over a 15-year period (2007-2022), and to compare the proportions before and after the introduction of routine varicella vaccination.
methodsThis retrospective cohort study included 641 patients (15 years old or older) diagnosed with APFP, including Bell's palsy, ZSH, and RHS, between July 2007 and December 2022 at a single institution in Hokkaido, Japan. Varicella-zoster virus (VZV) reactivation was diagnosed using an enzyme-linked immunosorbent assay with paired serum samples. The ratio of HZ was defined as the proportion of ZSH and RHS cases among all APFP patients.
resultsVZV reactivation was confirmed in 219 of 641 patients (34.2%). The proportion of HZ-related facial palsy was 33.6% (102/304) before the introduction of routine varicella vaccination and 34.7% (117/337) afterward, showing no significant overall change. However, among patients aged 15-29 years, the proportion of HZ significantly increased from 38.9% (14/36) before vaccination to 63.3% (19/30) after vaccination. This corresponds to an odds ratio of 2.714 (95% CI: 1.009-7.301), indicating that individuals in this age group had approximately 2.7 times higher odds of developing HZ-related facial palsy in the postvaccination period compared with the prevaccination period. The chi-square statistic (χ² = 3.910) and p-value (p = 0.048) further support that this increase is statistically significant.
conclusionsAlthough the overall incidence of HZ-related facial palsy among APFP patients did not change significantly after the implementation of routine varicella vaccination in 2014, a marked increase was observed in younger patients aged 15-29 years. These findings suggest a need for heightened clinical awareness of VZV reactivation in young generation presenting with APFP in Hokkaido, Japan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.